Copyright Reports & Markets. All rights reserved.

Global Bacterial Vaginosis Drug Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Bacterial Vaginosis Drug Market Overview

      • 1.1 Product Overview and Scope of Bacterial Vaginosis Drug
      • 1.2 Bacterial Vaginosis Drug Segment by Type
        • 1.2.1 Global Bacterial Vaginosis Drug Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Rx
        • 1.2.3 OTC
      • 1.3 Bacterial Vaginosis Drug Segment by Application
        • 1.3.1 Bacterial Vaginosis Drug Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Pharmacy
        • 1.3.4 Other
      • 1.3 Global Bacterial Vaginosis Drug Market by Region
        • 1.3.1 Global Bacterial Vaginosis Drug Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Bacterial Vaginosis Drug Market Size
        • 1.4.1 Global Bacterial Vaginosis Drug Revenue (2014-2025)
        • 1.4.2 Global Bacterial Vaginosis Drug Production (2014-2025)

      2 Global Bacterial Vaginosis Drug Market Competition by Manufacturers

      • 2.1 Global Bacterial Vaginosis Drug Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Bacterial Vaginosis Drug Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Bacterial Vaginosis Drug Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Bacterial Vaginosis Drug Production Sites, Area Served, Product Types
      • 2.5 Bacterial Vaginosis Drug Market Competitive Situation and Trends
        • 2.5.1 Bacterial Vaginosis Drug Market Concentration Rate
        • 2.5.2 Bacterial Vaginosis Drug Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Bacterial Vaginosis Drug Production Market Share by Regions

      • 3.1 Global Bacterial Vaginosis Drug Production Market Share by Regions
      • 3.2 Global Bacterial Vaginosis Drug Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Bacterial Vaginosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Bacterial Vaginosis Drug Production
        • 3.4.1 North America Bacterial Vaginosis Drug Production Growth Rate (2014-2019)
        • 3.4.2 North America Bacterial Vaginosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Bacterial Vaginosis Drug Production
        • 3.5.1 Europe Bacterial Vaginosis Drug Production Growth Rate (2014-2019)
        • 3.5.2 Europe Bacterial Vaginosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Bacterial Vaginosis Drug Production (2014-2019)
        • 3.6.1 China Bacterial Vaginosis Drug Production Growth Rate (2014-2019)
        • 3.6.2 China Bacterial Vaginosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Bacterial Vaginosis Drug Production (2014-2019)
        • 3.7.1 Japan Bacterial Vaginosis Drug Production Growth Rate (2014-2019)
        • 3.7.2 Japan Bacterial Vaginosis Drug Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Bacterial Vaginosis Drug Consumption by Regions

      • 4.1 Global Bacterial Vaginosis Drug Consumption by Regions
      • 4.2 North America Bacterial Vaginosis Drug Consumption (2014-2019)
      • 4.3 Europe Bacterial Vaginosis Drug Consumption (2014-2019)
      • 4.4 China Bacterial Vaginosis Drug Consumption (2014-2019)
      • 4.5 Japan Bacterial Vaginosis Drug Consumption (2014-2019)

      5 Global Bacterial Vaginosis Drug Production, Revenue, Price Trend by Type

      • 5.1 Global Bacterial Vaginosis Drug Production Market Share by Type (2014-2019)
      • 5.2 Global Bacterial Vaginosis Drug Revenue Market Share by Type (2014-2019)
      • 5.3 Global Bacterial Vaginosis Drug Price by Type (2014-2019)
      • 5.4 Global Bacterial Vaginosis Drug Production Growth by Type (2014-2019)

      6 Global Bacterial Vaginosis Drug Market Analysis by Applications

      • 6.1 Global Bacterial Vaginosis Drug Consumption Market Share by Application (2014-2019)
      • 6.2 Global Bacterial Vaginosis Drug Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Bacterial Vaginosis Drug Business

      • 7.1 Bayer
        • 7.1.1 Bayer Bacterial Vaginosis Drug Production Sites and Area Served
        • 7.1.2 Bacterial Vaginosis Drug Product Introduction, Application and Specification
        • 7.1.3 Bayer Bacterial Vaginosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Pfizer
        • 7.2.1 Pfizer Bacterial Vaginosis Drug Production Sites and Area Served
        • 7.2.2 Bacterial Vaginosis Drug Product Introduction, Application and Specification
        • 7.2.3 Pfizer Bacterial Vaginosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Sanofi
        • 7.3.1 Sanofi Bacterial Vaginosis Drug Production Sites and Area Served
        • 7.3.2 Bacterial Vaginosis Drug Product Introduction, Application and Specification
        • 7.3.3 Sanofi Bacterial Vaginosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Piramal
        • 7.4.1 Piramal Bacterial Vaginosis Drug Production Sites and Area Served
        • 7.4.2 Bacterial Vaginosis Drug Product Introduction, Application and Specification
        • 7.4.3 Piramal Bacterial Vaginosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Abbott
        • 7.5.1 Abbott Bacterial Vaginosis Drug Production Sites and Area Served
        • 7.5.2 Bacterial Vaginosis Drug Product Introduction, Application and Specification
        • 7.5.3 Abbott Bacterial Vaginosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Galderma
        • 7.6.1 Galderma Bacterial Vaginosis Drug Production Sites and Area Served
        • 7.6.2 Bacterial Vaginosis Drug Product Introduction, Application and Specification
        • 7.6.3 Galderma Bacterial Vaginosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Mission
        • 7.7.1 Mission Bacterial Vaginosis Drug Production Sites and Area Served
        • 7.7.2 Bacterial Vaginosis Drug Product Introduction, Application and Specification
        • 7.7.3 Mission Bacterial Vaginosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Alkem
        • 7.8.1 Alkem Bacterial Vaginosis Drug Production Sites and Area Served
        • 7.8.2 Bacterial Vaginosis Drug Product Introduction, Application and Specification
        • 7.8.3 Alkem Bacterial Vaginosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Xiuzheng
        • 7.9.1 Xiuzheng Bacterial Vaginosis Drug Production Sites and Area Served
        • 7.9.2 Bacterial Vaginosis Drug Product Introduction, Application and Specification
        • 7.9.3 Xiuzheng Bacterial Vaginosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Teva
        • 7.10.1 Teva Bacterial Vaginosis Drug Production Sites and Area Served
        • 7.10.2 Bacterial Vaginosis Drug Product Introduction, Application and Specification
        • 7.10.3 Teva Bacterial Vaginosis Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Perrigo
      • 7.12 West-Ward
      • 7.13 HPGC
      • 7.14 Yunnan Baiyao
      • 7.15 Starpharma
      • 7.16 Novel
      • 7.17 Edenvridge

      8 Bacterial Vaginosis Drug Manufacturing Cost Analysis

      • 8.1 Bacterial Vaginosis Drug Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Bacterial Vaginosis Drug
      • 8.4 Bacterial Vaginosis Drug Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Bacterial Vaginosis Drug Distributors List
      • 9.3 Bacterial Vaginosis Drug Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Bacterial Vaginosis Drug Market Forecast

      • 11.1 Global Bacterial Vaginosis Drug Production, Revenue Forecast
        • 11.1.1 Global Bacterial Vaginosis Drug Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Bacterial Vaginosis Drug Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Bacterial Vaginosis Drug Price and Trend Forecast (2019-2025)
      • 11.2 Global Bacterial Vaginosis Drug Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Bacterial Vaginosis Drug Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Bacterial Vaginosis Drug Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Bacterial Vaginosis Drug Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Bacterial Vaginosis Drug Production, Revenue Forecast (2019-2025)
      • 11.3 Global Bacterial Vaginosis Drug Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Bacterial Vaginosis Drug Consumption Forecast (2019-2025)
        • 11.3.2 Europe Bacterial Vaginosis Drug Consumption Forecast (2019-2025)
        • 11.3.3 China Bacterial Vaginosis Drug Consumption Forecast (2019-2025)
        • 11.3.4 Japan Bacterial Vaginosis Drug Consumption Forecast (2019-2025)
      • 11.4 Global Bacterial Vaginosis Drug Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Bacterial Vaginosis Drug Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria.
        The classification of bacterial vaginosis drug includes Rx and OTC, and the proportion of OTC in 2016 is about 72%.

        Bacterial vaginosis drug is widely sold in hospital, pharmacy and other field. The most proportion of bacterial vaginosis drug is sold in pharmacy, and the revenue in 2016 is about 423 M USD.

        USA region is the largest supplier of bacterial vaginosis drug, with a revenue market share nearly 32% in 2016. Europe is the second largest supplier of Bacterial Vaginosis Drug, enjoying revenue market share nearly 30% in 2016.

        USA and Europe are the largest consumption places, with the consumption market share nearly 28% in 2016.

        Market competition is intense. Bayer, Pfizer, Sanofi, Piramal, Abbott, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

        The global Bacterial Vaginosis Drug market is valued at 800 million US$ in 2018 is expected to reach 1030 million US$ by the end of 2025, growing at a CAGR of 3.2% during 2019-2025.
        This report focuses on Bacterial Vaginosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bacterial Vaginosis Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Bayer
        Pfizer
        Sanofi
        Piramal
        Abbott
        Galderma
        Mission
        Alkem
        Xiuzheng
        Teva
        Perrigo
        West-Ward
        HPGC
        Yunnan Baiyao
        Starpharma
        Novel
        Edenvridge

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Rx
        OTC

        Segment by Application
        Hospital
        Pharmacy
        Other

        Buy now